ONCS will be bought out during the NDA submission, if the price is right.
Usually pharmas wait but lately anything that starts with "immuno" is getting gobbled up. Look at DNDN, they are trying real hard to make them sell out. DNDN wants to go it alone. I said CHTP will be bought out and look what happened. I know MNKD will be bought out because I know Alfred Mann and I know ONCS will be bought out because the ASCO presentation will put out some feelers from some big corps. That's what they do, build relationships with smaller corps and get them for cheap. Kind of like the draft. If they are publicly traded they just devise a stock take-over. Nevertheless, the payoff is in the buyout, not in the approval.
That's my take--